These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24418411)

  • 41. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased ABCB1 expression in TP-110-resistant RPMI-8226 cells.
    Iijima M; Momose I; Ikeda D
    Biosci Biotechnol Biochem; 2010; 74(9):1913-9. PubMed ID: 20834157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
    Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Reversing effect of brassinolide on multidrug resistance of-CCRF-VCR1000 cells and a preliminary investigation on its mechanisms].
    Xian LJ; Li YQ; Liu RY; Cao QY; Sun J
    Yao Xue Xue Bao; 2005 Feb; 40(2):117-21. PubMed ID: 15875665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
    Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair.
    Dong J; Ren Y; Zhang T; Wang Z; Ling CC; Li GC; He F; Wang C; Wen B
    Oncol Rep; 2018 Mar; 39(3):912-920. PubMed ID: 29344644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin.
    Kim SH; Um JH; Dong-Won B; Kwon BH; Kim DW; Chung BS; Kang CD
    Leuk Res; 2000 Nov; 24(11):917-25. PubMed ID: 11086175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441.
    Tichy A; Durisova K; Salovska B; Pejchal J; Zarybnicka L; Vavrova J; Dye NA; Sinkorova Z
    Radiat Environ Biophys; 2014 Mar; 53(1):83-92. PubMed ID: 24100951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative resistance of idarubicin, doxorubicin and their C-13 alcohol metabolites in human MDR1 transfected NIH-3T3 cells.
    Kuffel MJ; Ames MM
    Cancer Chemother Pharmacol; 1995; 36(3):223-6. PubMed ID: 7781142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K.
    Munck JM; Batey MA; Zhao Y; Jenkins H; Richardson CJ; Cano C; Tavecchio M; Barbeau J; Bardos J; Cornell L; Griffin RJ; Menear K; Slade A; Thommes P; Martin NM; Newell DR; Smith GC; Curtin NJ
    Mol Cancer Ther; 2012 Aug; 11(8):1789-98. PubMed ID: 22576130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
    Chandra AN; Saravanabavan S; Rangan GK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.
    Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L
    J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NU7441 Enhances the Radiosensitivity of Liver Cancer Cells.
    Yang C; Wang Q; Liu X; Cheng X; Jiang X; Zhang Y; Feng Z; Zhou P
    Cell Physiol Biochem; 2016; 38(5):1897-905. PubMed ID: 27160694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity.
    Mudududdla R; Guru SK; Wani A; Sharma S; Joshi P; Vishwakarma RA; Kumar A; Bhushan S; Bharate SB
    Org Biomol Chem; 2015 Apr; 13(14):4296-309. PubMed ID: 25758415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA-PK Inhibition by NU7441 Enhances Chemosensitivity to Topoisomerase Inhibitor in Non-Small Cell Lung Carcinoma Cells by Blocking DNA Damage Repair.
    Yanai M; Makino H; Ping B; Takeda K; Tanaka N; Sakamoto T; Yamaguchi K; Kodani M; Yamasaki A; Igishi T; Shimizu E
    Yonago Acta Med; 2017 Mar; 60(1):9-15. PubMed ID: 28331416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity.
    Vellonen KS; Honkakoski P; Urtti A
    Eur J Pharm Sci; 2004 Oct; 23(2):181-8. PubMed ID: 15451006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing.
    Robert F; Barbeau M; Éthier S; Dostie J; Pelletier J
    Genome Med; 2015 Aug; 7(1):93. PubMed ID: 26307031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of DNA-PKcs activity re-sensitizes uveal melanoma cells to radio- and chemotherapy.
    Zhang B; Wu H; Hao J; Wu Y; Yang B
    Biochem Biophys Res Commun; 2020 Feb; 522(3):639-646. PubMed ID: 31785810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441.
    Waldrip ZJ; Acharya B; Armstrong D; Hanafi M; Rainwater RR; Amole S; Fulmer M; Azevedo-Pouly AC; Burns A; Burdine L; Frett B; Burdine MS
    Sci Rep; 2024 Aug; 14(1):19999. PubMed ID: 39198533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.